December 10, 2018
– sNDA seeks to expand Axumin® (fluciclovine F 18) label for use in detection and…
November 19, 2018
– Presented at 23rd Annual Scientific Meeting of the Society for Neuro-Oncology – BURLINGTON, Mass.…
November 15, 2018
BURLINGTON, Mass. and OXFORD, UK, November 14, 2018 – Blue Earth Diagnostics, a molecular imaging…
October 17, 2018
BURLINGTON, Mass. and OXFORD, UK, October 17, 2018 – Blue Earth Diagnostics, a molecular imaging…
October 12, 2018
Oxford, UK – October 12, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics…
October 2, 2018
Oxford, UK – October 2, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics…
September 11, 2018
- The Journal of Urology Publishes Results from Blue Earth Diagnostics’ LOCATE Trial of Role…
August 9, 2018
Oxford, UK – August 9, 2018 – Blue Earth Diagnostics, a leading molecular imaging diagnostics…
June 25, 2018
Supports Blue Earth Diagnostics’ goal to make Axumin commercially available across Europe Oxford, UK –…
June 18, 2018
BURLINGTON, Mass. and OXFORD, UK, June 18, 2018 – Blue Earth Diagnostics, a molecular imaging…
May 21, 2018
- Topline results presented at AUA 2018 evaluate clinical utility of 18F fluciclovine PET/CT imaging…
May 14, 2018
BURLINGTON, Mass. and OXFORD, UK, May 14, 2018 – Blue Earth Diagnostics, a molecular imaging…
